Top Markets
Coin of the day
Pascal Biosciences Inc. Pascal Biosciences Inc.

Pascal Biosciences Inc.

PSCBF
Κατάταξη σε μετοχές #37975
Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to... Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for oncology and bolstering immune system function. The company's robust pipeline includes several key candidates: PAS-403, a potent mitosis inhibitor designed to impede cancerous cell division, specifically targeting glioblastoma and secondary brain tumors; and PAS-393, an immunomodulatory cannabinoid developed to enhance the immune system's recognition of tumor cells when utilized alongside checkpoint inhibitor therapy. Furthermore, Pascal is progressing a specialized antibody therapy aimed at B-cells, intended for conditions like acute lymphoblastic leukemia and various B-cell lymphomas. The company is also investigating cannabinoid-derived products as potential treatments for COVID-19. To support its research, Pascal Biosciences maintains an exclusive licensing agreement with the University of Washington for a cannabinoid-based therapeutic against glioblastoma multiforme and brain metastases. It also benefits from a collaborative research partnership with SoRSE Technology Corporation, focused on advancing PAS-393 toward clinical trials. Founded in 2011, the company operates from its headquarters in Seattle, Washington.
Τιμή μετοχής
$0.1
Τελευταίος συγχρονισμός: 2024-06-18
Κεφαλαιοποίηση
$1.31M
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
0.00%
Χώρα
US
Εμπόριο Pascal Biosciences Inc. (PSCBF)

Κατηγορία

EPS για Pascal Biosciences Inc. (PSCBF)
EPS στις February 2024 TTM: $-0.01
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή της μετοχής της Pascal Biosciences Inc., το τρέχον EPS της εταιρείας (TTM) είναι $-0.01. Στο τέλος του 2022, η εταιρεία είχε EPS $-0.03, μείωση σε σύγκριση με το EPS του 2021 που ήταν $-0.07.
Ιστορικό EPS της Pascal Biosciences Inc. από 2019 έως 2026
EPS στο τέλος κάθε έτους
Έτος EPS Αλλαγή
2026 (TTM) $-0.01 -5.00%
2023 $-0.01 -54.55%
2022 $-0.03 -59.08%
2021 $-0.07 -21.22%
2020 $-0.09 -64.47%
2019 $-0.24 0.00%
EPS για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία EPS Διαφορά EPS Χώρα
$17.32 -182,415.79%
US
$27.74 -292,100.00%
NL
- -
CH
- -
KR
$13.70 -144,311.58%
BE